Traduction de «inspection of cell » (Néerlandais → Français) :

TERMINOLOGIE

anemie van Fanconi | familiale hypoplastische anemie | pancytopenie met misvormingen | '(Pure) red cell aplasia' | congenitaal | '(Pure) red cell aplasia' | van kinderen | '(Pure) red cell aplasia' | primair | syndroom van Blackfan-Diamond
Anémie (de):Fanconi | hypoplasique familiale | Erythroblastopénie (pure) (du):congénitale | nourrisson | primaire | Pancytopénie avec malformations Syndrome de Blackfan-Diamond

diffuus type GCT (giant cell tumor)
synovite villonodulaire pigmentée

giant cell-carcinoom van long
carcinome à cellules géantes du poumon

RCC - renal cell carcinoma
carcinome rénal

giant cell-pneumonie
pneumonie à cellules géantes

SEGA - subependymal giant cell astrocytoma
astrocytome sous-épendymaire à cellules géantes

chronic lymphoproliferative disorder of natural killer cells
leucémie chronique à grands lymphocytes granuleux à cellules NK

verworven 'pure red cell aplasia' [erytroblastopenie]
Aplasie médullaire acquise pure [érythroblastopénie]

indolente systemische-mastocytose | mastocytoma NNO | mestceltumor NNO | systemische mastocytose, geassocieerd met klonale hematopoëtische-`non-mast-cell-disease`(SM-AHNMD)
Mastocytome SAI Tumeur à mastocytes SAI

hairy-cell leukaemia
Leucémie à tricholeucocytes

TRADUCTIONS EN CONTEXTE

Inspection of cell and tissue banks.
Inspection of cell and tissue banks.

The external services of Unit II inspect manufacturers of medicines (in Belgium and non-EU countries), the wholesalers, the recognised laboratories, the companies recognised on the basis of the royal decree on raw materials used by the pharmacist, the manufacturers of “Active Pharmaceutical Ingredient” (API), blood establishments and cell and tissue banks.
The external services of Unit II inspect manufacturers of medicines (in Belgium and non-EU countries), the wholesalers, the recognised laboratories, the companies recognised on the basis of the royal decree on raw materials used by the pharmacist, the manufacturers of “Active Pharmaceutical Ingredient” (API), blood establishments and cell and tissue banks.